Cited by 53Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsAmyotrophic Lateral Sclerosis Research

Effects on splicing and protein function of three mutations in codon N296 of tau in vitro

Grover, Andrew, DeTure, Michael, Yen, Shu-Hui, Hutton, Mike·2002·Neuroscience Letters

Abstract

Three Mutations were recently reported in the same codon (N296) in exon 10 of the tau gene. Two of these mutations, N296N and N296H, lead to a clinical syndrome similar to autosomal dominant fronto-temporal dementia with Parkinsonism linked to chromosome 17. In contrast the third mutation, delN296, gives rise to atypical progressive supranuclear palsy in individuals homozygous for the mutation, but in heterozygous individuals this mutation is incompletely penetrant and associated with a phenotype similar to idiopathic Parkinson's disease. Functional assays were employed to determine the effects of these mutations on alternative splicing of exon 10, on microtubule assembly and self-aggregation of recombinant tau protein. We demonstrate that these mutations exhibit a spectrum of potentially pathogenic changes in tau function, and provide insight into the possible cause of the incompletely penetrant phenotype of the delN296 mutation.

Integrity signals

Registry

Crossref · 10.1016/s0304-3940(02)00124-6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • N296H causes increased inclusion of MAPT exon 10, leading to an overrepresentation of tau isoforms with four microtubule-binding repeats (4R tau).

    “Like many other familial FTD mutations (Denk and Wade-Martins, 2009), N296H causes increased inclusion of MAPT exon 10, leading to an overrepresentation of tau isoforms with four microtubule-binding repeats, known as 4R tau (Grover et al., 2002; Yoshida et al., 2002).”

Cited by

Sorted by citations

Authors
Grover, A., DeTure, M., Yen, S.-H., & Hutton, M.
Affiliations
Mayo Clinic in Florida (US)
Corresponding author
Hutton, Mike
Venue
Neuroscience Letters
Publisher
Elsevier BV
Published
2002-04
Volume
323
Issue
1
Pages
33-36
ISSN
0304-3940 (ISSN-L)
OpenAlex
W2086425215
Cited by
53
References
0
Citations by year
2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 3 · 2013: 3 · 2012: 1
FWCI
4.00
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroscience Letters (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Public Health Service
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
tau protein, exon 10, alternative splicing, microtubule assembly, frontotemporal dementia with parkinsonism linked to chromosome 17, progressive supranuclear palsy, Parkinson's disease, incomplete penetrance, protein function
MeSH terms
Codon, Dementia, Humans, Mutation, Parkinson Disease, tau Proteins, Alternative Splicing, Tauopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review